EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report) shot up 83.1% on Tuesday . The stock traded as high as $0.22 and last traded at $0.17. 780 shares changed hands during trading, a decline of 76% from the average session volume of 3,277 shares. The stock had previously closed at $0.10.
EV Biologics Price Performance
The business has a 50 day simple moving average of $0.19 and a 200-day simple moving average of $0.24.
EV Biologics Company Profile
EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.
Further Reading
- Five stocks we like better than EV Biologics
- With Risk Tolerance, One Size Does Not Fit All
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- The How and Why of Investing in Gold Stocks
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Short Selling – The Pros and Cons
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for EV Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EV Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
